Accessibility Menu
Mera Pharmaceuticals logo

Mera Pharmaceuticals(OTC) MRPI

Market Cap$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-100%
5 Year-100%
1 Year+0%
1 Month-99%
$0.00
+0.00%
+0.00Today
Mera Pharmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-28
Mera Pharmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-29
1 month-99%USD 0.002026-06-03
3 month+0%USD 0.002026-04-10
Year to date-99%USD 0.002025-12-08
1 year+0%USD 0.002025-06-18
3 year-99%USD 0.002023-07-25
5 year-99.99%USD 0.012021-07-29
Since inception-100%USD 0.201990-10-02

Mera Pharmaceuticals Financials at a Glance

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$302.62K

Net Income (TTM)

-$187.68K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-13.12 (Low)

Price

$0.00

Volume

199,700

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

MRPI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mera Pharmaceuticals

Mera Pharmaceuticals, Inc. is dedicated to the development and commercialization of natural products derived from microalgae, utilizing proprietary photobioreactor technology. The company also engages in sea salt development and operates a family entertainment center promoting health and wellness.

Products and Services
  • Natural products from microalgae
  • Sea salt development
  • Family entertainment center focused on health and wellness
Growth Outlook
  • Expansion into health and wellness markets is underway
  • Innovative product lines are being developed from microalgae
  • Potential for increased demand in sustainable food production
Financial Highlights
  • Recent quarterly revenue of 63,917 demonstrates market interest
  • Trailing twelve months show a gross profit margin of 96.5%
  • Operating cash flow improved to 2,741 in the latest quarter
Mera Pharmaceuticals, Inc. operates in the healthcare sector, specifically within the medical and pharmaceutical industry. The company has a market capitalization of approximately $55,730, indicating a niche presence in the market. The focus on natural products aligns with growing consumer trends towards sustainability and health-conscious choices. Recent financial data reveals a revenue of 63,917 for the latest quarter, reflecting a consistent interest in the company's offerings. The gross profit margin of 96.5% indicates strong potential for profitability, despite the challenges faced in the industry. The operating cash flow of 2,741 in the most recent quarter suggests a positive trend in cash management, which is crucial for ongoing operations and future growth initiatives. Mera Pharmaceuticals, Inc. continues to explore innovative avenues for growth, particularly in the health and wellness sectors. The company's commitment to developing sustainable products positions it well to capitalize on emerging market trends. As the demand for natural and health-oriented products increases, Mera Pharmaceuticals, Inc. may present an intriguing opportunity for investors interested in the evolving landscape of the pharmaceutical industry.
AI Generated • Jul 8, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Las Vegas, NV 89123, US

MRPI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

536.65M

Volume

199.70K

Avg. Volume

5.21K

Financials (TTM)

Gross Profit

$286.36K

Operating Income

-$201.05K

EBITDA

-$187.76K

Operating Cash Flow

-$71.84K

Capital Expenditure

$0.00

Free Cash Flow

-$74.13K

Cash & ST Invst.

$4.32K

Total Debt

$0.00

Mera Pharmaceuticals Performance Analysis

Mera Pharmaceuticals sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12011-01-310.7%
Q22011-04-3035.0%
Q32011-07-31-0.5%
Q42011-10-31-26.4%
Mera Pharmaceuticals sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12011-01-3185.7%
Q22011-04-30-9900.0%
Q32011-07-3199.7%
Q42011-10-31-595.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2011YOY CHG

Revenue

$63.92K

-0.4%

Gross Profit

$61.68K

+116.6%

Gross Margin

96.51%

N/A

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.76

N/A

Employees

74

N/A

Net Income

-$102.19K

+74.1%

EBITDA

-$101.43K

+74.1%

Quarterly Fundamentals

Name
Q4 2011YOY CHG

Total Cash

$4.32K

-27.4%

Total Debt

$0.00

N/A

Accounts Receivable

$7.85K

-11.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

18.75%

N/A

Free Cash Flow

-$72.19K

+50.2%

Operating Cash Flow

-$72.19K

-1518.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONBIONE Bio Corp.
$0.00+0.00%
LADXLadRx Corporation
$0.01-89.72%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About MRPI

What is the current price of Mera Pharmaceuticals?

Mera Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Mera Pharmaceuticals?

Over the past 52 weeks, Mera Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Mera Pharmaceuticals have?

Mera Pharmaceuticals total debt is unavailable.

How much cash does Mera Pharmaceuticals have on hand?

Mera Pharmaceuticals does not have cash on hand data available.

What is Mera Pharmaceuticals’s dividend yield?

Mera Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services